HSV-2 mRNA vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HSV-2 mRNA vaccine, covering 2026-01-09 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination [Phase 1]